Tofacitinib as a biologic response modifier in VEXAS syndrome: A case series.

Int J Rheum Dis

Central Adelaide Local Health Network, Adelaide, South Australia, Australia.

Published: November 2023

Download full-text PDF

Source
http://dx.doi.org/10.1111/1756-185X.14785DOI Listing

Publication Analysis

Top Keywords

tofacitinib biologic
4
biologic response
4
response modifier
4
modifier vexas
4
vexas syndrome
4
syndrome case
4
case series
4
tofacitinib
1
response
1
modifier
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!